Medical oncologist and health services researcher. Focusing on health care costs, physician-industry COI, and oncology reimbursement reform. Opinions mine.
Aaron Mitchell
Loading...
Presenting at #ASCO26 now!
Our new study: Bribes from the drug industry can lead oncologists to use WORSE treatments (not just better ones)
@ascocancer.bsky.social @mskcancercenter.bsky.social @dusetzinas.bsky.social @commonwealthfund.org @nihcm.bsky.social @arnoldventures.bsky.social
The webinar recording is now available, below.
I'm also looking forward to presenting these findings on Medicare Advantage and cancer care at @academyhealth.bsky.social #ARM26, this weekend!
cbiit.webex.com/recordingser...
I'll be presenting new findings at 2:15 PT today at #ARM26!
Our study measured provider profits on cancer drugs (profits have increased, a lot)
This looks like a great session, including other new findings on cancer care in MA. See you in ballroom 6C!
academyhealth.confex.com/academyhealt...
Here’s how he blew off 19 kids killed by Covid in 1 month.
Farewell #ARM26!
#ASCO26, see you in about 5 hours!
@ascocancer.bsky.social @academyhealth.bsky.social
New RCT evidence from @adrianna.bsky.social and coauthors testing effects of work requirements for SNAP
Some enrollees get exemptions, others did not
Work requirements had very small effects on employment, but large effects on enrollment
Preview of what to expect in Medicaid next year #ARM26
Excited to present preliminary results from a project that has been ongoing ~since I was a PhD student~ at today's late-breaking #ARM26 session — join us at 4p PT in rooms 613-614.
Hey, #ARM2026 attendees. Sorry I can't be with you in Seattle. Fellow some of these great health systems and health policy researchers and those in the know. If you want me to add you, feel free to comment here and I can. #hpss #hspr #hpsr #healthpolicy
Cancer care in the United States is deeply influenced by the structure of private and public insurance programs, where benefit design, provider incentives, and administrative requirements shape both c...
I appreciate this @jama.com commentary by Knox and @asarpatwari.bsky.social.
I'm among the skeptics of the 340B program as it currently operates, but it appears this proposed pilot would not address the major issues.
jamanetwork.com/journals/jam...
Webex by Cisco is an AI-powered secure enterprise collaboration platform.
This Viewpoint presents the history of the Health Resources & Services Administration (HRSA) 340B Drug Pricing Program and 340B Rebate Model Pilot Program, summarizes their controversies and limit...
Presenting our new study at #ASCO26 right now!
Provider profits on cancer drugs have grown 4-fold to $40 billion in the last decade and a half.
@ascocancer.bsky.social @mskcancercenter.bsky.social @hannahrabrams.bsky.social @nihcm.bsky.social
Aaron Mitchell
I'll be presenting some of our recent work on Medicare Advantage and its impacts on cancer care cost and quality, 3pm EST TODAY!
Part of ongoing NCI seminar series.
Webinar registration at the link below:
healthcaredelivery.cancer.gov/media/medica...
In normal times, the fact that government officials at HHS blatantly lied to the public and got caught would be a scandal of unusual size.
Everyone involved in this disinformation scheme against the people of the United States should be held accountable.
Aaron Mitchell
The agency’s analysis contradicts claims made by former vaccine chief Dr. Vinay Prasad.
